PATENT CLAIM ANALYSIS

Application Number: 16000670
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "400000"]

Abstract:
Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for subcutaneous injection, in particular analgesics such as buprenorphine.

Claim (Index 16):
The composition of  claim 2 , wherein buprenorphine is present in a dose of about 0.1, 0.2, 0.3, 0.4, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, 6.0, 6.5 or 7.0 mg/kg.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 94.0
- Lexical Diversity: 1.04545
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12855889', '14633545', '13193571', '14977680', '13754969']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6905421473902004
- 35 USC 102 Novelty (BERT): 0.5056989653427888
- Combined Prediction Score: 0.6720578291854592
- Mean Citation Score: 197.940104
- Max Citation Score: 206.80139
- Similarity Product: 134.4515418094182

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test